Genmab — April 2018

gentogen

Effect of Subcutaneous vs Intravenous Chronic Treatment with an Anti-CD20 Antibody on B-, T- and Myeloid Lymphocyte Subsets in Blood, Lymph Nodes and Spleen of C57BL/6 Mice (P2.410)
Anna Schubart, Gaelle Elain, Cindy Schmid, Julien Perdoux, Catherine Huck, David Leppert, Anis Mir, Gisbert Weckbecker
Neurology Apr 2018, 90 (15 Supplement) P2.410

gentogen

Chronic s.c. administration of an anti-CD20 antibody in mice induced a potent and long-lasting depletion of B cells. The quicker B-cell recovery in spleen with s.c. versus i.v. treatment may be linked to more favorable immunosurveillance and thereby may provide a potential benefit for patients requiring treatment cessation

E_L

that is a certainly much more easy to read I can't wait to see the Ofa results in MS

Bulder

After having enlarged the poster I think(!) it says the same about depletion of B-cells. But also that a reduction of CD4+ and CD8+ T-cells was transient and recovered at day 28(?). Also transient changes in granulocyte counts.

E_L

yes, also in that article from gentogen, here the link http://n.neurology.org/content/90/15_Supplement/P2.410

jkj

Er der abstrakt frigivelse til ASCO idag ?

jkj

Kun titler kan jeg sehttps://iplanner.asco.org/am2017/#/

jkj

og kun poster præsentationer kan jeg se.

jkj

Zymeworks er udvalgt til oral præsentation for deres ZW25, spændende canadisk biotekselskab som er værd at hold øje med.

HenryAS

Nordea skriver idag: Genmab kan komme i fokus efter solide Darzalex-salgstal for marts. Vi er positive på Genmab.

jkj

ja det er tydeligt at nordea har set dem og køber ind på dem, men ville nu være rart hvis vi andre også kendte dem.

AaBforever

Hvis Nordea har set tallene, så har A/B også.

HenryAS

Selve tallene oplyser de ikke iden meddelelse jeg har fået kun ovennævnte at de var solide

E_L

that is still 2017 jkj, but 2018 should be released today.

E_L

i think last year Genmab published an ASCO title list themselves, so i think i am going to be lazy and wait for that...

jkj

I hope your right EL, but how can zymeworks make a press release regarding ASCO and ZW25 if the titles are not public yet ?

AaBforever

A/B læser åbenbart tallene med andre briller på -:(

AaBforever

OHW

AB jeg tror ikke de tænker så meget!! De spiller på en generel og stor nedtur på aktiemarked som helhed og når det sker, er biotek blandt dem der falder mest.

E_L

I think they went a bit early with their press release and breached the embargo. i remember last year was available around 3 to 4PM